Janux Therapeutics, Inc. (JANX)
15.13
-0.17
(-1.11%)
USD |
NASDAQ |
Dec 15, 16:00
14.88
-0.25
(-1.65%)
After-Hours: 19:23
Janux Therapeutics Research and Development Expense (Annual): 68.39M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Stoke Therapeutics, Inc. | 86.96M |
| Ionis Pharmaceuticals, Inc. | 901.53M |
| Editas Medicine, Inc. | 193.44M |
| Entrada Therapeutics, Inc. | 121.53M |
| Belite Bio, Inc. | 29.94M |